Where our team of guest writers discuss what they think about the current NGP US Issues.
The pharmaceutical industry is more starved than ever for innovation – the most important strategy that every single pharmaceutical company relies on to grow and build their business.
A new pharmaceutical environment has arrived – one that requires pharmaceutical companies to make the clinical development process more productive and efficient.
Vito Mangiardi, President of North American Operations at AAIPharma, and David Spaight, President of MDS Pharma, talk clinical trials, ethical standards, CROs and where the industry is heading.
Mark P Clein, President and Co-Founder of the United BioSource Corporation, takes our eight questions challenge.
Bart Van de Vyver, Ph.D, CEO, Piero Zucchelli, Ph.D., CSO and Michael Biros, Head of Sales, North America, provide insight to the industry’s excitement over SpinX Technologies’ unique approach to nanoliter-scale assay automation.